We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo
ADLM 2025
Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Screening Method Developed for River Blindness

By LabMedica International staff writers
Posted on 12 Oct 2010
Scientists have developed a screening method that rapidly identifies individuals with active river blindness, or onchocerciasis.

The parasitic disease afflicts an estimated 37 million people and is caused by the larvae or microfilariae of the worm Onchocerca volvulus. The vast majority of onchocerciasis infections occur in sub-Saharan Africa, with the largest disease burden in rural Nigeria, and to a lesser degree in Yemen and in parts of Central and South America.

Scripps Research Institute (La Jolla, CA, USA) scientists used liquid chromatography-mass spectrometry (LC-MS) based metabolomics on an African sample set comprised of 73 serum and plasma samples to reveal 14 biomarkers that showed excellent discrimination between O. volvulus-positive and negative individuals.

Application of the biomarkers to an additional sample set from onchocerciasis endemic areas where long-term Ivermectin treatment was successful revealed that the biomarkers could distinguish individuals with worms of compromised viability from those with active infection.

The scientists plan to develop a diagnostic kit that can be used in the field to test for onchocerciasis and other parasitic diseases. There have not been any accurate, sensitive means of diagnosing O. volvulus infection. Clinical diagnostics are desperately needed in order to achieve the goals of controlling and eliminating onchocerciasis and neglected tropical diseases in general.

"A sensitive and reproducible diagnostic test for this disease is crucial for the success of worldwide control and elimination programs," said Kim Janda, Ph.D., a professor in the departments of chemistry and immunology and microbial science, member of The Skaggs Institute for Chemical Biology, and director of The Worm Institute for Research and Medicine (WIRM) at Scripps Research. "This diagnostic tool could be a game-changer for how the disease will be treated in the future."

The study was published online on October 5, 2010, by the journal PLOS Neglected Tropical Diseases.

Related Links:
Scripps Research Institute
The Skaggs Institute for Chemical Biology
The Worm Institute for Research and Medicine




New
Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Anterior Nasal Specimen Collection Swabs
53-1195-TFS, 53-0100-TFS, 53-0101-TFS, 53-4582-TFS
New
Gold Member
Hematology Analyzer
Medonic M32B

Latest Microbiology News

New Platform Leverages AI and Quantum Computing to Predict Salmonella Antimicrobial Resistance
12 Oct 2010  |   Microbiology

Early Detection of Gut Microbiota Metabolite Linked to Atherosclerosis Could Revolutionize Diagnosis
12 Oct 2010  |   Microbiology

Viral Load Tests Can Help Predict Mpox Severity
12 Oct 2010  |   Microbiology



PURITAN MEDICAL